$HR
Healthcare Realty Trust Inc Stock $hr

$hr Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 8-K Financial Statement

#000136060422000123 Filed on August 09, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$200.1M	$202.0M	$195.7M
YoY Change	6.11%	5.49%	55.44%
Cost Of Revenue	$57.01M	$57.46M	$60.29M
YoY Change	-0.7%	10.08%	20.11%
Gross Profit	$88.32M	$85.43M	$135.4M
YoY Change	-32.69%	9.39%	78.88%
Gross Profit Margin	44.13%	42.29%	69.19%
Selling, General & Admin	$10.54M	$11.04M	$17.49M
YoY Change	-3.56%	29.84%	142.92%
% of Gross Profit	11.93%	12.92%	12.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$41.44M	$71.01M	$70.97M
YoY Change	-54.93%	41.73%	47.54%
% of Gross Profit	46.93%	83.12%	52.41%
Operating Expenses	$66.27M	$65.08M	$94.02M
YoY Change	-22.86%	11.05%	69.71%
Operating Profit	$22.05M	$20.35M	$41.39M
YoY Change	-51.33%	4.37%	103.9%
Interest Expense	$24.76M	$23.94M	-$22.91M
YoY Change	7.03%	4.15%	67.2%
% of Operating Profit	112.31%	117.62%	-55.34%
Other Income/Expense, Net	$134.0K	$88.00K	$84.00K
YoY Change	-55.92%	2833.33%
Pretax Income	$6.130M	$42.23M	$16.61M
YoY Change	-84.18%	75.95%	-204.47%
Income Tax
% Of Pretax Income
Net Earnings	$14.17M	$18.32M	$16.30M
YoY Change	-62.73%	-16.86%	-202.53%
Net Earnings / Revenue	7.08%	9.07%	8.33%
Basic Earnings Per Share	$0.06	$0.08
Diluted Earnings Per Share	$0.06	$0.08	$71.05K
COMMON SHARES
Basic Shares Outstanding	229.1M shares	229.0M shares	220.8M shares
Diluted Shares Outstanding	233.1M shares	233.0M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.31M	$10.94M	$52.35M
YoY Change	73.33%	-9.55%	242.18%
Cash & Equivalents	$29.71M	$10.94M	$52.35M
Short-Term Investments
Other Short-Term Assets		$42.73M	$38.30M
YoY Change		-9.08%	-16.74%
Inventory
Prepaid Expenses
Receivables		$3.009M	$10.48M
Other Receivables		$153.8M	$148.7M
Total Short-Term Assets	$34.31M	$210.5M	$249.8M
YoY Change	-83.54%	1639.4%	1532.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.095B	$6.392B	$6.413B
YoY Change	-34.83%	82.04%	81.83%
Goodwill			$3.487M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$62.10M	$62.50M	$62.80M
YoY Change	-2.36%	-2.34%	-2.48%
Other Assets	$0.00	$63.15M	$83.85M
YoY Change	-100.0%	-2.25%	307.03%
Total Long-Term Assets	$6.781B	$6.604B	$6.640B
YoY Change	4.05%	-1.2%	-2.0%
TOTAL ASSETS
Total Short-Term Assets	$34.31M	$210.5M	$249.8M
Total Long-Term Assets	$6.781B	$6.604B	$6.640B
Total Assets	$6.815B	$6.815B	$6.890B
YoY Change	1.34%	1.77%	1.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$84.21M	$159.7M	$198.1M
YoY Change	-51.23%	140.45%	143.94%
Accrued Expenses	$94.75M	$196.2M	$196.3M
YoY Change	-51.46%	113.52%	112.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$179.0M	$434.7M	$480.6M
YoY Change	-60.35%	174.58%	177.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.126B	$3.054B	$3.028B
YoY Change	-30.83%	87.59%	86.74%
Other Long-Term Liabilities	$66.10M	$30.00M	$36.66M
YoY Change	62.36%	-56.96%	-46.71%
Total Long-Term Liabilities	$2.192B	$3.084B	$3.065B
YoY Change	-29.61%	81.65%	81.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$179.0M	$434.7M	$480.6M
Total Long-Term Liabilities	$2.192B	$3.084B	$3.065B
Total Liabilities	$3.574B	$3.519B	$3.545B
YoY Change	0.24%	0.31%	-0.29%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$5.185B	$5.183B	$5.180B
YoY Change	5.35%	5.36%	5.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.159B	$2.213B	$3.258B
YoY Change
Total Liabilities & Shareholders Equity	$6.815B	$6.815B	$6.890B
YoY Change	1.34%	1.77%	1.46%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$14.17M	$18.32M	$16.30M
YoY Change	-62.73%	-16.86%	-202.53%
Depreciation, Depletion And Amortization	$41.44M	$71.01M	$70.97M
YoY Change	-54.93%	41.73%	47.54%
Cash From Operating Activities	$64.81M	$49.31M	$114.0M
YoY Change	-56.33%	-24.55%	94.87%
INVESTING ACTIVITIES
Capital Expenditures	-$282.1M	-$58.03M	-$151.0M
YoY Change	423.52%	-31.09%	-34.19%
Acquisitions
YoY Change
Other Investing Activities	$34.10M	$24.85M	$8.446M
YoY Change	539.24%	72.54%	-112.82%
Cash From Investing Activities	-$248.0M	-$33.18M	-$142.5M
YoY Change	410.81%	-56.51%	-51.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.641M
YoY Change		-49.48%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	246.0M	-$57.78M	66.13M
YoY Change	-296.6%	-22.69%	-4.71%
NET CHANGE
Cash From Operating Activities	64.81M	$49.31M	114.0M
Cash From Investing Activities	-248.0M	-$33.18M	-142.5M
Cash From Financing Activities	246.0M	-$57.78M	66.13M
Net Change In Cash	62.78M	-$41.65M	37.60M
YoY Change	-348.88%	-51.39%	-122.46%
FREE CASH FLOW
Cash From Operating Activities	$64.81M	$49.31M	$114.0M
Capital Expenditures	-$282.1M	-$58.03M	-$151.0M
Free Cash Flow	$346.9M	$107.3M	$265.0M
YoY Change	71.47%	-28.23%	-7.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001360604
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Document Type DocumentType	8-K
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-08-09
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	Healthcare Realty Trust Incorporated
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022Q3	dei	Entity File Number EntityFileNumber	001-35568
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4738467
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	3310 West End Avenue, Suite 700
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville,
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2022Q3	dei	City Area Code CityAreaCode	(615)
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	269-8175
CY2022Q3	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value per share
CY2022Q3	dei	Trading Symbol TradingSymbol	HR
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q3	dei	Written Communications WrittenCommunications	false
CY2022Q3	dei	Soliciting Material SolicitingMaterial	false
CY2022Q3	dei	Pre Commencement Tender Offer PreCommencementTenderOffer	false
CY2022Q3	dei	Pre Commencement Issuer Tender Offer PreCommencementIssuerTenderOffer	false
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	us-gaap	Land Land	648394000	usd
CY2021Q4	us-gaap	Land Land	640382000	usd
CY2022Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	6774818000	usd
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	6688516000	usd
CY2022Q2	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	382738000	usd
CY2021Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	404714000	usd
CY2022Q2	us-gaap	Development In Process DevelopmentInProcess	15252000	usd
CY2021Q4	us-gaap	Development In Process DevelopmentInProcess	32685000	usd
CY2022Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	7821202000	usd
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	7766297000	usd
CY2022Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1699546000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1598468000	usd
CY2022Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6121656000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6167829000	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	27070000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	62070000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	62834000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29714000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52353000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4559000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4716000	usd
CY2022Q2	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	360433000	usd
CY2021Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	334941000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	227603000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	229226000	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	9315000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	10720000	usd
CY2022Q2	us-gaap	Assets Assets	6815350000	usd
CY2021Q4	us-gaap	Assets Assets	6889689000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	3094643000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	3028122000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	171673000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	198078000	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	262000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5069000	usd
CY2022Q2	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	82071000	usd
CY2021Q4	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	86225000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	196991000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196286000	usd
CY2022Q2	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	28671000	usd
CY2021Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	31331000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3574049000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3545373000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	229072922	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	229072922	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	228879846	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	228879846	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2291000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2289000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5182766000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5178132000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5786000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7041000	usd
CY2022Q2	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	2032181000	usd
CY2021Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1915776000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3158662000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3257604000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	82639000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	86712000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3241301000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3344316000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6815350000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6889689000	usd
CY2022Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	198284000	usd
CY2021Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	188494000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	398527000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	379844000	usd
CY2022Q2	us-gaap	Interest Income Operating InterestIncomeOperating	1849000	usd
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	121000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	3608000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	264000	usd
CY2022Q2	us-gaap	Revenues Revenues	200133000	usd
CY2021Q2	us-gaap	Revenues Revenues	188615000	usd
	us-gaap	Revenues Revenues	402135000	usd
	us-gaap	Revenues Revenues	380108000	usd
CY2022Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	63373000	usd
CY2021Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	57409000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	129257000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	116988000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14243000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10929000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26691000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21489000	usd
CY2022Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5107000	usd
CY2021Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11125000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q2	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	97000	usd
CY2021Q2	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	66000	usd
	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	241000	usd
	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	162000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75051000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	74977000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	150437000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	151251000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	24760000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	23133000	usd
	us-gaap	Interest Expense InterestExpense	48700000	usd
	us-gaap	Interest Expense InterestExpense	46119000	usd
CY2022Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2021Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	16825000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	16825000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	182631000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	183339000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	366451000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	352834000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	32753000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-4000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	32753000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3615000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3615000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	401000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	406000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	801000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	798000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	134000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	304000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	222000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	307000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	14422000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	38739000	usd
	us-gaap	Profit Loss ProfitLoss	33088000	usd
	us-gaap	Profit Loss ProfitLoss	61132000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	254000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	728000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	605000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1091000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	14168000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	38011000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32483000	usd
	us-gaap	Net Income Loss NetIncomeLoss	60041000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229074000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218822000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229026000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218787000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233125000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222326000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233086000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222297000	shares
CY2022Q2	us-gaap	Profit Loss ProfitLoss	14422000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	38739000	usd
	us-gaap	Profit Loss ProfitLoss	33088000	usd
	us-gaap	Profit Loss ProfitLoss	61132000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	4085000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1523000	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	75900000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	12902000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	4315000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4085000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1523000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12902000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4315000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	18507000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	40262000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	45990000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	65447000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	281000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	754000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	681000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1161000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18226000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	39508000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45309000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	64286000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3234919000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3337000	usd
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3248000	usd
CY2021Q1	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	usd
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.320
CY2021Q1	us-gaap	Dividends Dividends	71206000	usd
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	22393000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2792000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3188987000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2065000	usd
CY2021Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	129000	usd
CY2021Q2	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	usd
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.320
CY2021Q2	us-gaap	Dividends Dividends	71297000	usd
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	38739000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1523000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3159888000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3344316000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2024000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1640000	usd
CY2022Q1	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.325
CY2022Q1	us-gaap	Dividends Dividends	75816000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	18666000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8817000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3296367000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2191000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.325
CY2022Q2	us-gaap	Dividends Dividends	75760000	usd
CY2022Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	14422000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4085000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3241301000	usd
	us-gaap	Profit Loss ProfitLoss	33088000	usd
	us-gaap	Profit Loss ProfitLoss	61132000	usd
	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	142174000	usd
	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	142062000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4216000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5402000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	801000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	798000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1565000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1565000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	16825000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-4000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	32753000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3615000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	8445000	usd
	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	-10540000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22188000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8552000	usd
	hta	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-775000	usd
	hta	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-4496000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	152453000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190927000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	25855000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	50628000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	22478000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	33983000	usd
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	26791000	usd
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	65349000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	54954000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	53471000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	15405000	usd
	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	325000	usd
	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	3734000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	61020000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79905000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-118348000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	150000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	85000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	55000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7154000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1646000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3377000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	148826000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	140022000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	2718000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	2607000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95344000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-101006000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22796000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28427000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57069000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118765000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34273000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90338000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Organization and Description of Business <div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership, in an umbrella partnership, or “UPREIT” structure. HTA has qualified and intends to continue to be taxed as a REIT for federal income tax purposes under the applicable sections of the Internal Revenue Code of 1986, as amended. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own real estate primarily consisting of medical office buildings (“MOBs”) located on or adjacent to hospital campuses or in off-campus, community core outpatient locations across 32 states within the United States, and we lease space to tenants primarily consisting of health systems, research and academic institutions, and various sized physician practices. Through our full-service operating platform, we provide leasing, asset management, acquisitions, development and other related services for our properties. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary objective is to maximize stockholder value with growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing, building services and property management oversight; (ii) target accretive acquisitions and developments of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. Additionally, from time to time we consider, on an opportunistic basis, significant portfolio acquisitions that we believe fit our core business and we expect to enhance our existing portfolio.</span></div><div style="margin-top:3pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Healthcare Realty Trust Incorporated</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2022, Healthcare Trust of America, Inc. (the “Company”), a Maryland corporation, Healthcare Trust of America Holdings, LP, a Delaware limited partnership (the “Company OP”) of which the Company is the sole general partner, HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly owned subsidiary of the Company (“Merger Sub”), consummated a Merger with Healthcare Realty Trust Incorporated, a Maryland corporation (“HR”), pursuant to a definitive Agreement and Plan of Merger (the “Merger Agreement”) dated February 28, 2022, which was unanimously approved by the boards of directors of the Company and HR. Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub merged with and into HR, with HR surviving the Merger (the “Merger”). </span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms in the Merger Agreement, each outstanding share of Common Stock, $0.01 par value per share, of HR (“HR Common Stock”) was converted into the right to receive 1.0 (the “Exchange Ratio”) share of Class A Common Stock, $0.01 par value per share, of the Company (“Company Common Stock” and, such consideration, the “Merger Consideration”). Pursuant to the closing of the Merger and the other transactions contemplated therein, the holders of shares of Company Common Stock issued and outstanding on July 19, 2022 received a special distribution in the amount of $4.82 in cash per share of Company Common Stock held on such date (the “Special Distribution Payment”). </span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where noted, the condensed consolidated financial statements for the quarter ended June 30, 2022, descriptions of the Company, legal structure, employees, management, board of directors, customers, capitalization, risks and uncertainties, plans and objectives, strategy, and portfolio information solely relate to the Company prior to the consummation of the Merger without giving specific consideration to the combined entity post-Merger or plans of the Company’s management after the Merger.</span></div><div style="margin-top:3pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div>On March 11, 2020 the novel coronavirus disease (“COVID-19”) was declared a pandemic by the World Health Organization. As the virus continued to spread throughout the United States and other countries across the world, Federal, state and local governments took various actions including the issuance of “stay-at-home” orders, social distancing guidelines and ordering the temporary closure of non-essential businesses to limit the spread of COVID-19. While many businesses have reopened and vaccinations are becoming more widely available to the general population, the economic uncertainty created by the COVID-19 pandemic continues to present risks to the Company and the future results of our operations. Although we did not experience significant disruptions from the COVID-19 pandemic during the six months ended June 30, 2022, should current and planned measures, including further development and delivery of vaccines and other measures intended to reduce or eliminate the spread of COVID-19, past and/or proposed economic stimulus, and other laws, acts and orders proposed or enacted by these various governmental agencies ultimately not be successful or limited in their efficacy, our business and the broader real estate industry may experience significant adverse consequences. These consequences include loss of revenues, increased expenses, increased costs of materials, difficulty in maintaining an active workforce, and constraints on our ability to secure capital or financing, among other factors.
CY2022Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32	state
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that effect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent asset and liabilities. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in adverse ways, and those estimates could be different under different assumptions or conditions.
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29714000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19796000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4559000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	70542000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34273000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90338000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50
CY2021Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	62100000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	62800000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	800000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	800000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	25700000	usd
	hta	Asset Acquisition Transaction Costs Capitalized AssetAcquisitionTransactionCostsCapitalized	200000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand	3812000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand	1093000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements	19761000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements	45629000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	2121000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	5291000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	28000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	79000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	0	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	66000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests	0	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests	1372000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet	25666000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet	50628000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	0	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	2397000	usd
CY2022Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	25666000	usd
CY2021Q2	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	53025000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y2M12D
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y2M12D
	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P4Y1M6D
	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P5Y8M12D
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	16800000	usd
	hta	Number Of Assets Impaired NumberOfAssetsImpaired	2	property
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	403286000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	426251000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	210279000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	213801000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	193007000	usd
CY2022Q2	hta	Number Of Ground Leases Commenced NumberOfGroundLeasesCommenced	1	lease
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212450000	usd
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2022Q2	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	25024000	usd
CY2021Q4	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	23742000	usd
CY2022Q2	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	28671000	usd
	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P14Y7M6D
CY2021Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	31331000	usd
CY2021	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P14Y3M18D
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	10131000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	10477000	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	10335000	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	6098000	usd
CY2022Q2	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	7697000	usd
CY2021Q4	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	7055000	usd
CY2022Q2	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	48418000	usd
CY2021Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	45008000	usd
CY2022Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	149602000	usd
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	142604000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	34549000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	38301000	usd
CY2022Q2	us-gaap	Derivative Assets DerivativeAssets	7721000	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2022Q2	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	75872000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	69114000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16108000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16284000	usd
CY2022Q2	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	360433000	usd
CY2021Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	334941000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2296000	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2204000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4523000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4427000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1560000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	431000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2913000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	862000	usd
	hta	Number Of Ground Leases Commenced NumberOfGroundLeasesCommenced	1	lease
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5378000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	316000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10884000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	635000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10411000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	640000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9899000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	645000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9901000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	656000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9886000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	668000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	591325000	usd
CY2022Q2	hta	Equity Offering Program Availablefor Issuance EquityOfferingProgramAvailableforIssuance	750000000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	36856000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	647684000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	40416000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	450693000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	23506000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	196991000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	16910000	usd
CY2022Q2	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	198000000	usd
CY2021Q2	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	187400000	usd
CY2022Q2	us-gaap	Variable Lease Income VariableLeaseIncome	47400000	usd
CY2021Q2	us-gaap	Variable Lease Income VariableLeaseIncome	42200000	usd
	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	397300000	usd
	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	377800000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	95500000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	87300000	usd
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	75800000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	290284000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	551493000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	495354000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	436400000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	388471000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	318837000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	1345024000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3825863000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3115000000	usd
CY2022Q3	us-gaap	Distribution Made To Limited Partner Distributions Declared Per Unit DistributionMadeToLimitedPartnerDistributionsDeclaredPerUnit	4.82
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3050000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16426000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17975000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3931000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3903000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	3094643000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	3028122000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	365000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	600000000	usd
CY2022Q2	hta	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1950000000	usd
CY2020Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3115000000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3600000	usd
CY2022Q2	hta	Deferred Finance Costs Future Amortization Expense Remainder Of Fiscal Year DeferredFinanceCostsFutureAmortizationExpenseRemainderOfFiscalYear	1554000	usd
CY2022Q2	hta	Deferred Finance Costs Amortization Expense Year One DeferredFinanceCostsAmortizationExpenseYearOne	3107000	usd
CY2022Q2	hta	Deferred Finance Costs Amortization Expense Year Two DeferredFinanceCostsAmortizationExpenseYearTwo	2725000	usd
CY2022Q2	hta	Deferred Finance Costs Amortization Expense Year Three DeferredFinanceCostsAmortizationExpenseYearThree	2604000	usd
CY2022Q2	hta	Deferred Finance Costs Amortization Expense Year Four DeferredFinanceCostsAmortizationExpenseYearFour	1839000	usd
CY2022Q2	hta	Deferred Finance Costs Amortization Expense After Year Four DeferredFinanceCostsAmortizationExpenseAfterYearFour	4597000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16426000	usd
CY2022Q2	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	5600000	usd
CY2022Q2	hta	Derivative Asset Including Interest Excluding Adjustment For Nonperformance Risk DerivativeAssetIncludingInterestExcludingAdjustmentForNonperformanceRisk	7800000	usd
CY2022Q3	us-gaap	Distribution Made To Limited Partner Distributions Paid Per Unit DistributionMadeToLimitedPartnerDistributionsPaidPerUnit	4.82
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	300000000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	14422000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	38739000	usd
	us-gaap	Profit Loss ProfitLoss	33088000	usd
	us-gaap	Profit Loss ProfitLoss	61132000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	254000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	728000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	605000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1091000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	14168000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	38011000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32483000	usd
	us-gaap	Net Income Loss NetIncomeLoss	60041000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229074000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218822000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229026000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218787000	shares
CY2022Q2	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	4051000	shares
CY2021Q2	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	3504000	shares
	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	4060000	shares
	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	3510000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233125000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222326000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233086000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222297000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Interest Paid Net InterestPaidNet	50284000	usd
	us-gaap	Interest Paid Net InterestPaidNet	39827000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7609000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7942000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6244000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13065000	usd
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	75765000	usd
CY2021Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	71302000	usd
	hta	Noncash Redemption Of Noncontrolling Interests NoncashRedemptionOfNoncontrollingInterests	2065000	usd
	hta	Noncash Redemption Of Noncontrolling Interests NoncashRedemptionOfNoncontrollingInterests	546000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	705000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7683000	usd

Files In Submission

Name	View Source	Status
0001360604-22-000123-index-headers.html	Edgar Link	pending
0001360604-22-000123-index.html	Edgar Link	pending
0001360604-22-000123.txt	Edgar Link	pending
0001360604-22-000123-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hta-20220809.htm	Edgar Link	pending
hta-20220809.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
hta-20220809_pre.xml	Edgar Link	unprocessable
hta-20220809_lab.xml	Edgar Link	unprocessable
hta-20220809_def.xml	Edgar Link	unprocessable
hta-20220809_cal.xml	Edgar Link	unprocessable
hta-20220809_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HR
Healthcare Realty Trust Inc Stock $hr

2022 Q2 Form 8-K Financial Statement

#000136060422000123 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR Healthcare Realty Trust Inc Stock $hr

2022 Q2 Form 8-K Financial Statement

#000136060422000123 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR
Healthcare Realty Trust Inc Stock $hr